Arrayjet
Arrayjet is a leading microarray company that provides solutions to researchers and development groups across academia, biotechnology, pharma and diagnostics. Their patented inkjet platform combines the fastest and most reliable bioprinting instruments with the versatility to print any biological sample type onto any solid substrate.
Latest Arrayjet Content
Poster
Accelerate Drug Discovery With Small Molecule Microarrays
This poster explores how small molecule microarrays (SMM) simplifies the drug discovery workflow, from microarray printing to target screening, delivering fast, reliable results.
Article
Trends in Target-Based Drug Discovery
In this article, we highlight how target discovery has advanced and explore the growing role that computational approaches are playing in modern drug target identification.
Product
Advertisement
Mercury Microarrayers: pL-nL Inkjet Liquid Handling
Harnessing 20 years of experience, Arrayjet's microarray spotters are the fastest ultra low-volume dispensers on the market. With patented inkjet microarray technology, they can print any type of biological sample onto any substrate, up to 10 times faster than the closest alternative.
Product News
Arrayjet’s ArrayPlex Platform Selected by Immunome for Use in Its Discovery of Targeted Cancer Therapies
Arrayjet’s patented spot-on-spot microarray screening technology is available for customers to adopt in-house and via Arrayjet’s CRO/CMO services.
Product News
Arrayjet Announces Collaboration With Chemspace To Augment Its Small Molecule Microarray Services for Drug Discovery
Arrayjet, announced that it has partnered with Chemspace, the largest online catalogue of small molecules and biologics, to augment and streamline the Company’s small molecule microarray (SMM) service offering.
Industry Insight
Innovations and Versatility in Modern Microarray Technology
In this interview, CEO of Arrayjet Dr. Iain McWilliam discusses advancements in modern microarray technology and the benefits that these tools can provide for high-throughput screening.
Advertisement
